Fig. 4From: Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysisThe mRNA expression levels of prognostic hub gene in liver hepatocellular carcinoma (LIHC) in subgroup analyses. The published online data of gene mRNA expression level were analyzed by UALCAN platform. Subgroup analyses were performed based on patients’ LIHC stages (a–d) and TP53 mutation status (e–h). T test was performed on the relevant results (*P<0.05, **P<0.01,***P<0.001)Back to article page